Myoepithelial Carcinoma: A Rare and Potentially Aggressive Salivary Gland Malignancy




Table of Contents

Myoepithelial carcinoma (MC) is an uncommon malignant neoplasm of the salivary glands composed predominantly of neoplastic myoepithelial cells. It may arise de novo or from malignant transformation of a pre-existing pleomorphic adenoma or benign myoepithelioma. Although some tumors exhibit low-grade features, myoepithelial carcinoma is generally considered potentially aggressive, with a risk of local recurrence and distant metastasis.

Definition and Classification

Myoepithelial carcinoma is defined by malignant proliferation of cells showing myoepithelial differentiation, without a significant ductal component. The World Health Organization recognizes MC as a distinct salivary gland carcinoma.

The tumor may show a variety of cellular morphologies, including:

- Spindle cells
- Plasmacytoid (hyaline) cells
- Epithelioid cells
- Clear cells

This morphologic diversity contributes to diagnostic difficulty.

Epidemiology and Etiology

- Rare tumor, accounting for <1% of salivary gland malignancies
- Occurs across a wide age range, most commonly in adults
- No strong gender predilection
- Etiology is poorly understood
- May develop from long-standing pleomorphic adenoma or benign myoepithelioma

Common Sites of Occurrence

Myoepithelial carcinoma arises in both major and minor salivary glands:

- Parotid gland (most common)
- Submandibular gland
- Minor salivary glands of the palate, buccal mucosa, and lips

Minor salivary gland lesions are often diagnosed late due to their indolent appearance.

Clinical Presentation

Clinical features are variable and may include:

- Slow- or rapidly growing salivary gland mass
- Firm or fixed swelling
- Pain or tenderness in advanced lesions
- Facial nerve dysfunction (parotid tumors)
- Ulceration in intraoral lesions

Clinical behavior is unpredictable and not always correlated with histologic appearance.

Diagnostic Approach

Accurate diagnosis requires integration of clinical findings, histopathology, and immunohistochemistry.

Key steps include:

- Imaging (CT or MRI) to assess local invasion
- Incisional biopsy for definitive diagnosis
- Histopathological examination
- Extensive immunohistochemical profiling

Immunohistochemistry

Tumor cells typically express:

- Myoepithelial markers: S100, calponin, smooth muscle actin (SMA), p63
- Cytokeratins
- Variable Ki-67 proliferation index (higher in aggressive tumors)

Loss of myoepithelial marker expression may indicate high-grade transformation.

Histopathological Features

Microscopic characteristics include:

- Infiltrative growth pattern
- Cellular pleomorphism and atypia
- Increased mitotic activity
- Necrosis in high-grade tumors
- Absence or minimal presence of ductal structures
- Possible perineural and lymphovascular invasion

The diagnosis of malignancy is based on invasive growth, cytologic atypia, and mitotic activity rather than architectural pattern alone.

Differential Diagnosis

Myoepithelial carcinoma must be differentiated from:

- Benign myoepithelioma
- Pleomorphic adenoma
- Epithelial-myoepithelial carcinoma
- Clear cell carcinoma
- Sarcomatoid carcinoma

Immunohistochemistry is essential for accurate distinction.

Management and Treatment

Management depends on tumor grade and extent but is generally aggressive:

- Wide surgical excision with clear margins
- Neck dissection in cases with nodal involvement
- Adjuvant radiotherapy for high-grade, invasive, or recurrent tumors
- Chemotherapy has limited effectiveness and is reserved for advanced disease

Long-term follow-up is essential due to the risk of late recurrence.

Prognosis

- Prognosis is variable and depends on tumor grade and stage
- Local recurrence rates range from 30–50%
- Distant metastasis (lung, bone) may occur, especially in high-grade tumors
- Overall survival is poorer than for low-grade salivary gland carcinomas

Role of Dental and Medical Professionals

Dental professionals play a crucial role in:

- Early detection of suspicious salivary gland lesions
- Monitoring long-standing benign tumors for malignant change
- Prompt referral for biopsy and specialist care
- Post-treatment oral rehabilitation and surveillance

For students, myoepithelial carcinoma highlights the importance of recognizing cell lineage differentiation and understanding the role of immunohistochemistry in salivary gland pathology.

Conclusion

Myoepithelial carcinoma is a rare but clinically significant salivary gland malignancy with unpredictable behavior. Accurate diagnosis relies on careful histopathologic assessment supported by immunohistochemical confirmation of myoepithelial differentiation. Early surgical management and diligent long-term follow-up are essential to optimize patient outcomes.


Report aproblem

Post a Comment

Previous Post Next Post
Update cookies preferences